ArticleNeurology. Genetics2020
Hemorrhagic cerebral small vessel disease caused by a novel mutation in 3' UTR of collagen type IV alpha 1.
Open access · goldAbstract read
In one paragraph
Article in Neurology. Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 7 citations in OpenAlex.
- A patient with pontine autosomal dominant microangiopathy and leukoencephalopathy caused by a de novo 3' untranslated region mutation of COL4A1 gene: case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Multiple microbleeds in a patient with pontine autosomal dominant microangiopathy and leukoencephalopathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Article
- High frequency ofJournal of neurology, neurosurgery, and psychiatry · 2023Article
- 'Raisin bread sign' feature of pontine autosomal dominant microangiopathy and leukoencephalopathy.Brain communications · 2023Article
- A Novel Mutation in COL4A1 Gene in a Chinese Family with Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy.Translational stroke research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Naoko SakaiDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Masahiro UemuraDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.ORCID 0000-0003-0645-0099
Taisuke KatoDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Hiroaki NozakiDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Akihide KoyamaDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Shouichirou AndoDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Hiroyuki KameiDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Motohiro KatoDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.
Osamu OnoderaDepartment of Neurology (N.S., M.U., S.A., O.O.), Brain Research Institute, Niigata University, Japan; Department of System Pathology for Neurological Disorders (T.K.), Brain Research Institute, Niigata University, Japan; Department of Medical Technology (H.N.), Graduate School of Health Sciences, Niigata University, Japan; Department of Legal Medicine (A.K.), Niigata University Graduate School of Medical and Dental Science, Japan; and Department of Neurology (H.K., M.K.), Fukuoka Mirai Hospital, Japan.ORCID 0000-0003-3354-5472
Mirai Hospital · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.